| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Noxopharm Limited (AU: NOX)
NOX Technical Analysis
4
| As on 27th Nov 2025 NOX STOCK Price closed @ 0.08 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.09 & Strong Sell for SHORT-TERM with Stoploss of 0.09 we also expect STOCK to react on Following IMPORTANT LEVELS. |
NOXSTOCK Price
| Open | 0.09 | Change | Price | % |
| High | 0.09 | 1 Day | -0.01 | -11.11 |
| Low | 0.08 | 1 Week | -0.01 | -11.11 |
| Close | 0.08 | 1 Month | -0.02 | -20.00 |
| Volume | 40256 | 1 Year | -0.02 | -20.00 |
| 52 Week High 0.12 | 52 Week Low 0.04 | ||||
AU Australia Most Active Stocks
| LKE | 0.07 | 16.67% |
| AVE | 0.01 | 0.00% |
| SGQ | 0.10 | 11.11% |
| WAF | 2.81 | 3.69% |
| NSR | 2.71 | 1.12% |
| RML | 0.07 | 16.67% |
| CXO | 0.22 | 0.00% |
| LNU | 0.00 | % |
| PIL | 0.00 | % |
| ATC | 0.03 | 0.00% |
AU Australia Top Gainers Stocks
AU Australia Top Losers Stocks
| NOX Daily Charts |
NOX Intraday Charts |
Whats New @ Bazaartrend |
NOX Free Analysis |
|
|
NOX Important Levels Intraday
| RESISTANCE | 0.10 |
| RESISTANCE | 0.09 |
| RESISTANCE | 0.09 |
| RESISTANCE | 0.09 |
| SUPPORT | 0.07 |
| SUPPORT | 0.07 |
| SUPPORT | 0.07 |
| SUPPORT | 0.06 |
NOX Forecast November 2025
| 4th UP Forecast | 0.12 |
| 3rd UP Forecast | 0.11 |
| 2nd UP Forecast | 0.1 |
| 1st UP Forecast | 0.09 |
| 1st DOWN Forecast | 0.07 |
| 2nd DOWN Forecast | 0.06 |
| 3rd DOWN Forecast | 0.05 |
| 4th DOWN Forecast | 0.04 |
NOX Weekly Forecast
| 4th UP Forecast | 0.08 |
| 3rd UP Forecast | 0.08 |
| 2nd UP Forecast | 0.08 |
| 1st UP Forecast | 0.08 |
| 1st DOWN Forecast | 0.08 |
| 2nd DOWN Forecast | 0.08 |
| 3rd DOWN Forecast | 0.08 |
| 4th DOWN Forecast | 0.08 |
NOX Forecast2025
| 4th UP Forecast | 0.27 |
| 3rd UP Forecast | 0.21 |
| 2nd UP Forecast | 0.17 |
| 1st UP Forecast | 0.13 |
| 1st DOWN Forecast | 0.03 |
| 2nd DOWN Forecast | -0.01 |
| 3rd DOWN Forecast | -0.05 |
| 4th DOWN Forecast | -0.11 |
Noxopharm Limited ( AU Australia Symbol : NOX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
NOX Business Profile
Noxopharm Limited, a drug development company, engages in the research and development of drugs for the treatment of cancer and prevention of septic shock in Australia and internationally. It primarily develops Veyonda, which is an adjuvant therapy in chemotherapy and radiotherapy for the treatment of late-stage cancers. The company also develops DARRT program that is in Phase 1b/2a for the treatment of metastatic castration-resistant prostate cancer and other solid tumors; LuPIN with combined therapy of Veyonda and 177Lu-PSMA-617 for the treatment of late-stage prostate cancer; IONIC program with Veyonda, which is combined with the Bristol Myers Squibb checkpoint inhibitor Opdivo for the treatment of various solid tumor types; and chemotherapy enhancement program (CEP) combined with carboplatin for patients with refractory solid tumors in the breast, head and neck, lung, prostate, and ovaries. In addition, it develops NOXCOVID Program, a dose escalation and dose expansion study of NOX66 for the treatment of COVID-19 infection. Noxopharm Limited has a partnership with Hudson Institute of Medical Research and a collaboration with The Australian National University to develop a better treatment for septic shock, as well as materials cooperative research and development agreement with the U.S. National Cancer Institute for treatment of brain cancer. The company was incorporated in 2015 and is based in Chatswood, Australia. Address: Tower A, The Zenith, Chatswood, NSW, Australia, 2067
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service